Since Meg3 can interact with p53 directly (25,26,28), it is possible that the interaction between Meg3 and p53 could competitively prevent the binding of p53…
B, ERBB4 activation by fusion. had been suppressed by tyrosine kinase inhibitors accepted for clinical make use of. Conclusions: Oncogenic fusions become drivers mutations in…
Since oftentimes these cell populations are characterized based on genetic markers that actually label heterogenous populations (Debnath et al., 2018; Tikhonova et al., 2019), beneath…